Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Election of Yujiro S. Hata to Board of Directors
The Board of Directors of Enanta Pharmaceuticals, Inc. has elected Yujiro S.
Hata to serve as an independent director of the company in the class of
directors whose term expires at Enanta's 2024 annual meeting of stockholders.
This election, which was effective on August 19, 2021, increases the number of
directors to seven. The Board of Directors also appointed Mr. Hata to be a
member of the Compensation Committee and the Nominating and Corporate Governance
Committee of the Board of Directors. Mr. Hata will receive the standard cash
compensation for non-employee directors of Enanta, including retainer fees for
Board and committee service. In addition, he received a non-statutory stock
option to purchase 13,144 shares of Enanta's Common Stock, which will vest over
36 months. Mr. Hata will also have the benefit of Enanta's standard form of
indemnification agreement for non-employee directors.
1
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses